Journal
CELL CYCLE
Volume 9, Issue 3, Pages 486-497Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.9.3.10508
Keywords
Akt; kinase; ubiquitination; phosphorylation; TRAF6; E3 ligase; PDK1; mTORC2; NF kappa B; tumorigenesis
Categories
Funding
- National Science Council fund [NSC-97-2911-I-182-004-2]
- China Scholarship Council fund
Ask authors/readers for more resources
Akt (also known as PKB) signaling orchestrates many aspects of biological functions and, importantly, its deregulation is linked to cancer development. Akt activity is well-known regulated through its phosphorylation at T308 and S473 by PDK1 and mTORC2, respectively. Although in the last decade the research has been primarily focused on Akt phosphorylation and its role in Akt activation and functions, other posttranslational modifications on Akt have never been reported. Until very recently, a novel posttranslational modification on Akt termed ubiquitination was identified and shown to play an important role in Akt activation. The cancer-associated Akt mutant recently identified in a subset of human cancers displays enhanced Akt ubiquitination, in turn contributing to Akt hyperactivation, suggesting a potential role of Akt ubiquitination in cancers. Thus, this novel posttranslational modification on Akt reveals an exciting avenue that has advanced our current understandings of how Akt signaling activation is regulated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available